查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790398

美國電生理映射消融設備市場規模、佔有率和趨勢分析報告：按程序類型、產品範圍和細分市場預測，2025 年至 2033 年

U.S. Electrophysiology Mapping And Ablation Devices Market Size, Share & Trends Analysis Report By Procedure Type (EP Ablation Procedures, Stand-Alone EP Diagnostic Procedures), By Product Coverage, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國電生理映射消融設備市場摘要

美國電生理標測消融設備市場規模預計在 2024 年為 104.7 億美元，預計到 2033 年將達到 231.1 億美元，2025 年至 2033 年的複合年成長率為 8.05%。美國採用電生理 (EP) 標測消融設備是由於心房顫動和其他複雜心律不整的負擔日益加重，尤其是在老化和高風險族群中。

美國肥胖、高血壓和糖尿病發病率的上升導致外科手術數量增加，並加速了對先進電生理 (EP) 診斷和治療技術的需求。根據美國疾病管制與預防中心 (CDC) 預測，到 2030 年，美國將有約 1,210 萬人受心房顫動影響。美國心律不整（尤其是心房顫動）的負擔日益加重，推動了電生理 (EP) 標測和消融設備的普及。

隨著醫院和專科中心擴大其心臟病學項目，對能夠更快、更準確診斷和更有針對性治療的工具的需求日益成長。 2020年3月，《臨床心臟病學》雜誌發表了一項對美國心律不整相關死亡的25年分析報告，報告稱，1999年至2023年，35歲及以上成年人死亡人數為505萬。死亡率從1999年到2009年下降，隨後穩定上升，在2021年新冠疫情期間達到頂峰，隨後略有下降。

技術進步仍然是市場成長的關鍵驅動力。 3D 映射系統、脈衝電場消融平台和人工智慧導航等創新技術正在提高準確性並降低手術風險。這些技術在美國醫療保健提供者中越來越受到青睞，他們致力於簡化工作流程、改善治療效果，並在競爭日益激烈的電生理領域中佔據優勢。 2025 年 6 月，飛利浦 Medisize 推出了 TheraVolt，這是第一個專為高壓、高針數電生理 (EP) 映射和消融設備量身定做的品牌醫療連接器系列。 TheraVolt 旨在支援脈衝場消融治療，提供可客製化、可消毒的解決方案，具有高密度整合和平台靈活性。

美國日益增強的認知和篩檢力度正在加速 EP 技術的使用。社區健康計畫、健康系統主導的推廣以及主動心律監測有助於及早發現心律不整。隨著越來越多的患者在出現併發症之前得到診斷，對診斷和治療 EP 程序及支援設備的需求持續成長。 2025 年 7 月，PCNA 發布了一份白皮書，評估了馬裡蘭州巴爾的摩市以地區為基礎心房顫動 (AFib) 和高血壓篩檢舉措的成功經驗。該報告強調了早期和微創診斷解決方案的必要性，因為心房顫動由於其發作性而無法充分診斷，預計到 2030 年患病人數將增至 1210 萬人。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國電生理映射消融設備市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國電生理映射消融設備市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國電生理映射消融設備市場：程序類型估計和趨勢分析

  • 美國電生理標測消融設備：手術類型儀表板
  • 美國電生理標測消融設備：手術類型變異分析
  • 美國電生理映射消融設備市場規模、預測和趨勢分析（按程序類型）（2021-2033 年）
  • EP消融手術
    • 按指示
    • 心房顫動
    • 右心房撲動
    • 左心房撲動
    • 房室結迴旋性心搏過速（AVNRT）
    • 右房心搏過速（AT）
    • 左房心搏過速（AT）
    • 右側沃爾夫-巴金森-懷特氏症候群（WPW）
    • 左側沃爾夫-帕金森-懷特症候群（WPW）
    • 右心室心搏過速（VT）
    • 左心室心搏過速（VT）
    • 產品類型
  • 獨立 EP 診斷程序

第5章美國電生理映射消融設備市場：產品範圍估計與趨勢分析

  • 美國電生理映射消融設備市場：產品規格儀表板
  • 美國電生理映射消融設備市場：產品範圍變化分析
  • 美國電生理映射消融設備市場規模、預測和趨勢分析（按產品範圍）（2021-2033 年）
  • 地圖和實驗室系統
    • X光系統
    • 地圖系統
    • EP錄音系統
    • ICE系統
    • 射頻消融發生器
    • 脈衝電場消融發生器
    • 冷凍消融發生器
  • 診斷導管
    • 傳統的
    • 高級型
    • 超音波
  • 消融導管
    • 局部消融導管
    • 球囊消融導管
  • 附屬設備
    • 長期植入
    • 房間隔穿刺針
    • 導航配件

第6章 競爭態勢

  • 主要製造商的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • Key customers
    • Key company market share analysis, 2024
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Abbott
    • Johnson &Johnson（Biosense Webster）
    • GE HealthCare
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik SE &Co KG
    • MicroPort Scientific Corporation
    • CardioFocus, Inc.
Product Code: GVR-4-68040-694-8

U.S. Electrophysiology Mapping and Ablation Devices Market Summary

The U.S. electrophysiology mapping and ablation devices market size was estimated at USD 10.47 billion in 2024 and is projected to reach USD 23.11 billion by 2033, growing at a CAGR of 8.05% from 2025 to 2033. Widespread use of electrophysiology (EP) mapping and ablation devices in the U.S. is being driven by the escalating burden of atrial fibrillation and other complex arrhythmias, particularly among aging and at-risk populations.

As clinical guidelines increasingly favor early interventional treatment, hospitals and ambulatory centers are expanding their EP capabilities.Rising obesity rates, hypertension, and diabetes prevalence in the U.S. are contributing to increased procedure volumes and accelerating the demand for advanced diagnostic and therapeutic EP technologies. According to the CDC, approximately 12.1 million people in the U.S. will be suffering from atrial fibrillation by 2030. The growing burden of arrhythmias in the U.S., particularly atrial fibrillation, is driving increased adoption of electrophysiology (EP) mapping and ablation devices.

As hospitals and specialty centers expand their cardiac programs, there is a rising demand for tools that enable faster, more accurate diagnosis and targeted treatment. In March 202, Clinical Cardiology published a 25-year analysis of arrhythmia-related deaths in the U.S., reporting 5.05 million deaths among adults aged 35+ from 1999-2023. Mortality fell from 1999 to 2009, then rose steadily, peaking in 2021 during the COVID-19 pandemic before declining slightly.

Technological advancement remains a key driver of market growth. Innovations in 3D mapping systems, pulsed field ablation platforms, and AI-guided navigation are improving precision and reducing procedural risk. These technologies are gaining traction among U.S. providers seeking to streamline workflows, enhance outcomes, and stay ahead in an increasingly competitive electrophysiology landscape. In June 2025, Phillips Medisize launched TheraVolt, its first branded line of medical connectors tailored for high-voltage, high pin-count electrophysiology (EP) mapping and ablation devices. Designed to support pulsed field ablation therapies, TheraVolt offers customizable, sterilization-compatible solutions with high-density integration and platform flexibility.

Growing awareness and screening initiatives across the U.S. are accelerating the use of EP technologies. Community health programs, health system-led outreach, and proactive rhythm monitoring are helping identify arrhythmias earlier. As more patients are diagnosed before complications arise, demand for diagnostic and therapeutic EP procedures and the devices that support them continues to rise. In July 2025, a white paper published by PCNA evaluated the outcomes of a community-based screening initiative targeting atrial fibrillation (AFib) and hypertension in Baltimore, Maryland. The report noted that AFib remains underdiagnosed due to its episodic symptoms, underscoring the growing need for early, minimally invasive diagnostic solutions as cases are projected to rise to 12.1 million by 2030.

U.S. Electrophysiology Mapping And Ablation Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. electrophysiology mapping and ablation devices market report based on procedure type and product coverage:

  • Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
  • EP Ablation Procedures
    • By Indication
    • Atrial Fibrillation
    • Paroxysmal AF
    • Persistent AF
    • Long standing persistent/permanent
    • Right Atrial Flutter
    • Left Atrial Flutter
    • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
    • Right Atrial Tachycardia (AT)
    • Left Atrial Tachycardia (AT)
    • Right Wolff-Parkinson-White (WPW)
    • Left Wolff-Parkinson-White (WPW)
    • Right Ventricular Tachycardia (VT)
    • Left Ventricular Tachycardia (VT)
  • Stand-Alone EP Diagnostic Procedures
    • By Product Type
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Product Coverage Outlook (Revenue, USD Million, 2021 - 2033)
  • Mapping & Lab Systems
    • X-Ray Systems
    • Mapping Systems
    • EP Recording Systems
    • ICE Systems
    • RF Ablation Generators
    • Pulsed Field Ablation Generators
    • Cryoablation Generators
  • Diagnostic Catheters
    • Conventional
    • Fixed
    • Steerable
    • Advanced
    • Ultrasound
  • Ablation Catheters
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Accessory Devices
    • Long Introducer Sheaths
    • Fixed
    • Steerable
    • Transseptal Needles
    • Conventional
    • RF
    • Navigational Accessories

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure Type
    • 1.2.2. Product Coverage
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure Type Segment
    • 2.2.2. Product Coverage Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Electrophysiology Mapping and Ablation Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiac arrhythmias
      • 3.2.1.2. Ongoing technological innovation in EP mapping and ablation
      • 3.2.1.3. Expanding awareness and adoption of AFib screening programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced EP systems and ablation procedures
      • 3.2.2.2. Complex and evolving regulatory compliance requirements
  • 3.3. U.S. Electrophysiology Mapping and Ablation Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Estimates & Trend Analysis

  • 4.1. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Dashboard
  • 4.2. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Movement Analysis
  • 4.3. U.S. Electrophysiology Mapping and Ablation Devices Market Size & Forecasts and Trend Analysis, by Procedure Type, 2021 - 2033 (USD Million)
  • 4.4. EP Ablation Procedures
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. By Indication
    • 4.4.3. Atrial Fibrillation
      • 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Paroxysmal AF
        • 4.4.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Persistent AF
        • 4.4.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Long standing persistent/permanent
        • 4.4.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Right Atrial Flutter
      • 4.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Left Atrial Flutter
      • 4.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
      • 4.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.7. Right Atrial Tachycardia (AT)
      • 4.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.8. Left Atrial Tachycardia (AT)
      • 4.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.9. Right Wolff-Parkinson-White (WPW)
      • 4.4.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.10. Left Wolff-Parkinson-White (WPW)
      • 4.4.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.11. Right Ventricular Tachycardia (VT)
      • 4.4.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.12. Left Ventricular Tachycardia (VT)
      • 4.4.12.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.13. By Product Type
      • 4.4.13.1. Focal ablation catheter
        • 4.4.13.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.13.1.2. Radiofrequency (RF)
          • 4.4.13.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.13.1.2.2. Conventional
          • 4.4.13.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.13.1.2.3. Irrigated-tip
            • 4.4.13.1.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.4.13.1.2.3.2. Contact-force-sensing
            • 4.4.13.1.2.3.3. Standard
        • 4.4.13.1.3. Alternative energy
          • 4.4.13.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.13.1.4. Pulsed field ablation
          • 4.4.13.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.13.2. Balloon ablation catheters
        • 4.4.13.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Stand-Alone EP Diagnostic Procedures
    • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Estimates & Trend Analysis

  • 5.1. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Dashboard
  • 5.2. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Movement Analysis
  • 5.3. U.S. Electrophysiology Mapping and Ablation Devices Market Size & Forecasts and Trend Analysis, by Product Coverage, 2021 - 2033 (USD Million)
  • 5.4. Mapping & Lab Systems
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. X-Ray Systems
      • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Mapping Systems
      • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. EP Recording Systems
      • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. ICE Systems
      • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.6. RF Ablation Generators
      • 5.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.7. Pulsed Field Ablation Generators
      • 5.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.8. Cryoablation Generators
      • 5.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Diagnostic Catheters
    • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Conventional
      • 5.5.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.2. Fixed
        • 5.5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.3. Steerable
        • 5.5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Advanced
      • 5.5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Ultrasound
      • 5.5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ablation Catheters
    • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Focal Ablation Catheter
      • 5.6.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.2. Radiofrequency (RF)
        • 5.6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 5.6.2.2.2. Conventional
          • 5.6.2.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 5.6.2.2.3. Irrigated-tip
          • 5.6.2.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.6.2.2.3.2. Contact-force-sensing
            • 5.6.2.2.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.6.2.2.3.3. Standard
            • 5.6.2.2.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.3. Alternative energy
        • 5.6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.4. Pulsed field ablation
        • 5.6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. Balloon Ablation Catheters
      • 5.6.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Accessory Devices
    • 5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Long Introducer Sheaths
      • 5.7.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.2.2. Fixed
        • 5.7.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.2.3. Steerable
        • 5.7.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.3. Transseptal Needles
      • 5.7.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.3.2. Conventional
        • 5.7.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.3.3. RF
        • 5.7.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.4. Navigational Accessories
      • 5.7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. Siemens Healthineers
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Koninklijke Philips N.V.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Abbott
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Johnson & Johnson (Biosense Webster)
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. GE HealthCare
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Boston Scientific Corporation
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Medtronic
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Biotronik SE & Co KG
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. MicroPort Scientific Corporation
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. CardioFocus, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. U.S. electrophysiology mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Million)
  • Table 4. U.S. electrophysiology mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. electrophysiology mapping and ablation devices market: outlook
  • Fig. 9 U.S. electrophysiology (EP) mapping and ablation devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Ancillary market outlook
  • Fig. 12 U.S. electrophysiology mapping and ablation devices market driver impact
  • Fig. 13 U.S. electrophysiology mapping and ablation devices market restraint impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 U.S. electrophysiology mapping and ablation devices market: Procedure type movement analysis
  • Fig. 17 U.S. electrophysiology mapping and ablation devices market: Procedure type outlook and key takeaways
  • Fig. 18 EP ablation procedures market, 2021 - 2033 (USD Million)
  • Fig. 19 Atrial fibrillation market, 2021 - 2033 (USD Million)
  • Fig. 20 Paroxysmal AF market, 2021 - 2033 (USD Million)
  • Fig. 21 Persistent AF market, 2021 - 2033 (USD Million)
  • Fig. 22 Long standing persistent/permanent market, 2021 - 2033 (USD Million)
  • Fig. 23 Right atrial flutter market, 2021 - 2033 (USD Million)
  • Fig. 24 Left atrial flutter market, 2021 - 2033 (USD Million)
  • Fig. 25 Atrioventricular nodal reentry tachycardia (AVNRT) market, 2021 - 2033 (USD Million)
  • Fig. 26 Left atrial tachycardia (AT) market, 2021 - 2033 (USD Million)
  • Fig. 27 Right atrial tachycardia (AT) market, 2021 - 2033 (USD Million)
  • Fig. 28 Right wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Million)
  • Fig. 29 Left wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Million)
  • Fig. 30 Right ventricular tachycardia (VT) market, 2021 - 2033 (USD Million)
  • Fig. 31 Left ventricular tachycardia (VT) market, 2021 - 2033 (USD Million)
  • Fig. 32 Stand-alone EP diagnostic procedures market, 2021 - 2033 (USD Million)
  • Fig. 33 By product type market, 2021 - 2033 (USD Million)
  • Fig. 34 Focal ablation catheter market, 2021 - 2033 (USD Million)
  • Fig. 35 Radiofrequency (RF) market, 2021 - 2033 (USD Million)
  • Fig. 36 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 37 Irrigated-tip market, 2021 - 2033 (USD Million)
  • Fig. 38 Contact-force-sensing market, 2021 - 2033 (USD Million)
  • Fig. 39 Standard market, 2021 - 2033 (USD Million)
  • Fig. 40 Alternative energy market, 2021 - 2033 (USD Million)
  • Fig. 41 Pulsed field ablation market, 2021 - 2033 (USD Million)
  • Fig. 42 Balloon ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. electrophysiology mapping and ablation devices market: Product coverage movement analysis
  • Fig. 44 U.S. electrophysiology mapping and ablation devices market: Product coverage outlook and key takeaways
  • Fig. 45 Mapping & lab systems market, 2021 - 2033 (USD Million)
  • Fig. 46 X-ray systems market, 2021 - 2033 (USD Million)
  • Fig. 47 Mapping systems market, 2021 - 2033 (USD Million)
  • Fig. 48 EP recording systems market, 2021 - 2033 (USD Million)
  • Fig. 49 ICE systems market, 2021 - 2033 (USD Million)
  • Fig. 50 RF ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 51 Pulsed field ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 52 Cryoablation generators market, 2021 - 2033 (USD Million)
  • Fig. 53 Diagnostic catheters market, 2021 - 2033 (USD Million)
  • Fig. 54 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 55 Fixed market, 2021 - 2033 (USD Million)
  • Fig. 56 Steerable market, 2021 - 2033 (USD Million)
  • Fig. 57 Advanced market, 2021 - 2033 (USD Million)
  • Fig. 58 Ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 59 Ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 60 Focal ablation catheter market, 2021 - 2033 (USD Million)
  • Fig. 61 Radiofrequency (RF) market, 2021 - 2033 (USD Million)
  • Fig. 62 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 63 Irrigated-tip market, 2021 - 2033 (USD Million)
  • Fig. 64 Contact-force-sensing market, 2021 - 2033 (USD Million)
  • Fig. 65 Standard market, 2021 - 2033 (USD Million)
  • Fig. 66 Alternative energy market, 2021 - 2033 (USD Million)
  • Fig. 67 Pulsed field ablation market, 2021 - 2033 (USD Million)
  • Fig. 68 Balloon ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 69 Accessory devices market, 2021 - 2033 (USD Million)
  • Fig. 70 Long introducer sheaths market, 2021 - 2033 (USD Million)
  • Fig. 71 Fixed market, 2021 - 2033 (USD Million)
  • Fig. 72 Steerable market, 2021 - 2033 (USD Million)
  • Fig. 73 Transseptal needles market, 2021 - 2033 (USD Million)
  • Fig. 74 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 75 RF market, 2021 - 2033 (USD Million)
  • Fig. 76 Navigational accessories market, 2021 - 2033 (USD Million)
  • Fig. 77 Market participant categorization
  • Fig. 78 Strategy mapping
  • Fig. 79 Key company categorization
  • Fig. 80 Heat map analysis 2024